Amedica Corporation to Host Conference Call to Discuss Recent Sale of Spine Implant Business and Transition to Biomaterials Company
SALT LAKE CITY, Sept. 11, 2018 (GLOBE NEWSWIRE) — Amedica Corporation (NASDAQ: AMDA), a company that develops and commercializes silicon nitride for biomedical applications, announced today that it will host a conference call with Dr. Sonny Bal, Chairman and CEO of Amedica Corporation, to discuss the recently announced sale of its spine implant business to CTL Medical and its transition to a biomaterials company.
Details related to this call are as follows:
Date: Thursday, September 13, 2018
Time: 11:00 a.m., Eastern Time
Dial-in: Toll-free 877-524-8416
International 412-902-1028
Questions: Questions will not be taken during the call. Investors may submit questions prior to the call via email to IR@amedica.com. Questions will be accepted through 10:00 p.m. Mountain time on Tuesday, September 11, 2018.
For those who are not available to listen to the call, a digital replay will be archived on the investor relations section of the Amedica website under Events & Presentations.
About Amedica Corporation
Amedica is an innovative biomaterials and OEM company that develops and commercializes silicon nitride for various biomedical applications including orthopedic, dental and arthroplasty.
Contacts: Amedica IR 801-839-3502 IR@amedica.com
